Literature DB >> 30046999

Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1.

Heng Xiao1,2,3, Lamei Yuan1, Hongbo Xu1, Zhijian Yang1, Feizhou Huang4, Zhi Song2, Yan Yang2, Cheng Zeng1, Hao Deng5,6.   

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder primarily characterized by multiple café-au-lait macules, peripheral neurofibromas, skinfold freckling, and Lisch nodules. The causative genetic factor is the neurofibromin 1 gene (NF1), which encodes a Ras GTPase-activating protein called neurofibromin. NF1 variants may lead to loss of neurofibromin function and activation of downstream cell growth. This study aims to discover the disease-causing variants responsible for NF1 in two Han Chinese families by using exome sequencing combined with Sanger sequencing. A recurrent missense variant c.269T>C (p.Leu90Pro) and a novel nonsense variant c.2993dupA (p.Tyr998*) in the NF1 gene were identified. These variants co-segregated with the disorder in the pedigrees and were absent in the normal controls. The results broaden the NF1 mutation spectrum responsible for NF1. This may be helpful in genetic counseling, clinical management, and gene-targeted therapies for NF1.

Entities:  

Keywords:  Gene-targeted therapy; Genetic analysis; Genetic counseling; NF1 gene; Neurofibromatosis type 1

Mesh:

Substances:

Year:  2018        PMID: 30046999     DOI: 10.1007/s12031-018-1128-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  35 in total

1.  NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Authors:  Joseph A Toonen; Corina Anastasaki; Laura J Smithson; Scott M Gianino; Kairong Li; Robert A Kesterson; David H Gutmann
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

2.  Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.

Authors:  D Barker; E Wright; K Nguyen; L Cannon; P Fain; D Goldgar; D T Bishop; J Carey; B Baty; J Kivlin
Journal:  Science       Date:  1987-05-29       Impact factor: 47.728

3.  Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1.

Authors:  E Ars; E Serra; J García; H Kruyer; A Gaona; C Lázaro; X Estivill
Journal:  Hum Mol Genet       Date:  2000-01-22       Impact factor: 6.150

4.  Identification of a Premature Termination Mutation in the Proline-Rich Transmembrane Protein 2 Gene in a Chinese Family with Febrile Seizures.

Authors:  Wen Zheng; Jie Zhang; Xiong Deng; Jingjing Xiao; Lamei Yuan; Yan Yang; Liping Guan; Zhi Song; Zhijian Yang; Hao Deng
Journal:  Mol Neurobiol       Date:  2014-12-15       Impact factor: 5.590

5.  Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: toward a theory of genetic modifiers.

Authors:  Verena Wiest; Ingrid Eisenbarth; Claudia Schmegner; Winfrid Krone; Günter Assum
Journal:  Hum Mutat       Date:  2003-12       Impact factor: 4.878

6.  Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.

Authors:  C I Brannan; A S Perkins; K S Vogel; N Ratner; M L Nordlund; S W Reid; A M Buchberg; N A Jenkins; L F Parada; N G Copeland
Journal:  Genes Dev       Date:  1994-05-01       Impact factor: 11.361

7.  Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1.

Authors:  Jung Min Ko; Young Bae Sohn; Seon Yong Jeong; Hyon-Ju Kim; Ludwine M Messiaen
Journal:  Pediatr Neurol       Date:  2013-06       Impact factor: 3.372

8.  Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification.

Authors:  A De Luca; I Bottillo; M C Dasdia; A Morella; V Lanari; L Bernardini; L Divona; S Giustini; L Sinibaldi; A Novelli; I Torrente; A Schirinzi; B Dallapiccola
Journal:  J Med Genet       Date:  2007-12       Impact factor: 6.318

9.  p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas.

Authors:  Valentina Pinna; Valentina Lanari; Paola Daniele; Federica Consoli; Emanuele Agolini; Katia Margiotti; Irene Bottillo; Isabella Torrente; Alessandro Bruselles; Caterina Fusilli; Anna Ficcadenti; Sara Bargiacchi; Eva Trevisson; Monica Forzan; Sandra Giustini; Chiara Leoni; Giuseppe Zampino; Maria Cristina Digilio; Bruno Dallapiccola; Maurizio Clementi; Marco Tartaglia; Alessandro De Luca
Journal:  Eur J Hum Genet       Date:  2014-11-05       Impact factor: 4.246

10.  Identification of a Novel Mutation in the COL2A1 Gene in a Chinese Family with Spondyloepiphyseal Dysplasia Congenita.

Authors:  Xiangjun Huang; Xiong Deng; Hongbo Xu; Song Wu; Lamei Yuan; Zhijian Yang; Yan Yang; Hao Deng
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

View more
  4 in total

1.  Identification of DNAH17 Variants in Han-Chinese Patients With Left-Right Asymmetry Disorders.

Authors:  Xuehui Yu; Lamei Yuan; Sheng Deng; Hong Xia; Xiaolong Tu; Xiong Deng; Xiangjun Huang; Xiao Cao; Hao Deng
Journal:  Front Genet       Date:  2022-05-27       Impact factor: 4.772

2.  COL1A2 p.Gly1066Val variant identified in a Han Chinese family with osteogenesis imperfecta type I.

Authors:  Mingyuan Wang; Yi Guo; Pengfei Rong; Hongbo Xu; Lina Gong; Hao Deng; Lamei Yuan
Journal:  Mol Genet Genomic Med       Date:  2019-03-04       Impact factor: 2.183

3.  Identification of a novel EVC variant in a Han-Chinese family with Ellis-van Creveld syndrome.

Authors:  Xiangjun Huang; Yi Guo; Hongbo Xu; Zhijian Yang; Xiong Deng; Hao Deng; Lamei Yuan
Journal:  Mol Genet Genomic Med       Date:  2019-07-23       Impact factor: 2.183

4.  Identification of a frame shift mutation in the CCDC151 gene in a Han-Chinese family with Kartagener syndrome.

Authors:  Sheng Deng; Shan Wu; Hong Xia; Wei Xiong; Xiong Deng; Junxi Liao; Hao Deng; Lamei Yuan
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.